Ghi lại tin tức và câu chuyện địa phương
HONG KONG, Mar 31, 2023 – (ACN Newswire via SEAPRWire.com) – On 28th March 2023, Rxilient Biotech (a portfolio company of Legend Capital) and Junshi Biosciences made a joint announcement that …
ABUJA, NG, Mar 31, 2023 – (ACN Newswire via SEAPRWire.com) – Queen Jennifer Ephraim, a renowned beauty queen, humanitarian, and fundraising expert, recently launched a highly anticipated book titled “DILEMMA OF …
HONG KONG, Mar 31, 2023 – (ACN Newswire via SEAPRWire.com) – Yunkang Group Limited (“Yunkang” or the “Group”; Stock Code: 2325), a leading medical operation services provider in China, has announced …
TOKYO, Mar 30, 2023 – (JCN Newswire via SEAPRWire.com) – Hitachi, Ltd. (“Hitachi”), Honda Motor Co., Ltd (“Honda”), JICC-01 Limited Partnership (“JICC-01”) managed by JICC-01 G.K., which is a wholly owned …
TOKYO, Mar 30, 2023 – (JCN Newswire via SEAPRWire.com) – Honda Motor Co., Ltd. today announced a summary of automobile production, Japan domestic sales, and export results for the month of …
HONG KONG, Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – Ocumension Therapeutics (“Ocumension” or the “Company”, together with its subsidiaries, collectively the “Group”, stock code: 1477), a leading China ophthalmic …
HONG KONG, Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – Value Convergence Holdings Limited (“VC Holdings”, together with its subsidiaries, the “Group”; Stock Code: 0821.HK), a well-established and one-stop financial …
HONG KONG, Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – ESPRIT HOLDINGS LIMITED (the “Company”, together with its subsidiaries, “ESPRIT” or the “Group;” HKEx: 00330) has announced its audited financial …
HONG KONG, Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – Alltronics Holdings Limited (“Alltronics” or the “Group”) (SEHK: 833), a leading electronic products manufacturer and provider of energy-saving business solutions, …
FOSTER CITY, Calif., Mar 30, 2023 – (ACN Newswire via SEAPRWire.com) – Apollomics Inc. (“Apollomics” or the “Company”), a clinical-stage biopharmaceutical company developing multiple oncology drug candidates to address difficult-to-treat and …